Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 11/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.50 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.50 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9735999 | 0.99 | MEN1 (0.51) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| SCHEMBL10829614 | 0.93 | ABCB1 (0.48) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| SCHEMBL10829713 | 0.93 | ABCB1 (0.53) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| SCHEMBL10829647 | 0.92 | MEN1 (0.47) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| SCHEMBL10830174 | 0.92 | MEN1 (0.47) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| Hydrochloric Acid SCHEMBL10830300 | 0.92 | ABCB1 (0.53) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| Hydrochloric Acid SCHEMBL10829914 | 0.92 | ABCB1 (0.47) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| SCHEMBL9737421 | 0.92 | ABCB1 (0.45) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| Hydrochloric Acid SCHEMBL10830211 | 0.91 | MEN1 (0.46) | ABCB1ADRB2ADRB1ADRB3LMNA | |
| Hydrochloric Acid SCHEMBL10829709 | 0.91 | MEN1 (0.47) | ABCB1ADRB2ADRB1ADRB3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160229914-A1 | METHOD OF TREATING A PATHOLOGICAL SYNDROME | EPSHTEIN OLEG ILIICH (RU) | 2016-08-11 | — | — | US | disclosed |
| US-20160137750-A1 | METHOD OF TREATING A PATHOLOGICAL SYNDROME | EPSHTEIN OLEG IIIICH (RU) | 2016-05-19 | — | — | US | disclosed |
| US-9303091-B2 | Method of treating disorders of the cardiovascular system and a pharmaceutical agent | Epshtein, Oleg Iliich (RU) | 2016-04-05 | — | — | US | disclosed |
| US-9273117-B2 | Method for administering homeopathically potentized antibody | OLEG ILIICH EPSHTEIN (RU) | 2016-03-01 | — | — | US | disclosed |
| US-9228024-B2 | Method of treating hypertension disorder and a pharmaceutical agent | EPSHTEIN, OLEG I. (RU) | 2016-01-05 | — | — | US | disclosed |
| US-20140056923-A9 | METHOD OF TREATING HYPERTENSION DISORDER AND A PHARMACEUTICAL AGENT | EPSHTEIN, OLEG I. (RU) | 2014-02-27 | — | — | US | disclosed |
| US-8535664-B2 | Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction | Epshtein, Oleg I. (RU) | 2013-09-17 | — | — | US | disclosed |
| US-7815904-B2 | Method of treating a pathological syndrome and a pharmaceutical agent | Epshtein, Oleg Iliich (RU) | 2010-10-19 | — | — | US | disclosed |
| US-20100239569-A1 | Method Of Treating Disorders Of The Cardiovascular System And A Pharmaceutical Agent | OLEG ILIICH EPSHTEIN (RU) | 2010-09-23 | — | — | US | disclosed |
| US-20100166762-A1 | METHOD OF TREATING A PATHOLOGICAL SYNDROME | Epshtein, Oleg Iliich (RU) | 2010-07-01 | — | — | US | disclosed |
| US-20080019982-A1 | Method of treating a pathological syndrome and a pharmaceutical agent | EPSHTEIN, OLEG I. (RU) | 2008-01-24 | — | — | US | disclosed |
| US-20070224187-A1 | Method of treating a pathological syndrome and a pharmaceutical agent | EPSHTEIN, OLEG I. (RU) | 2007-09-27 | — | — | US | disclosed |
| US-20030099636-A1 | Curing method for pathologic syndrome and medicinal preparation | EPSHTEIN, OLEG I. (RU) | 2003-05-29 | — | — | US | disclosed |
| EP-1295606-A1 | CURING METHOD FOR PATHOLOGIC SYNDROME AND A MEDICINAL PREPARATION | Epshtein, Oleg Iliich (RU) | 2003-03-26 | — | — | EP | disclosed |
| EP-0462150-B1 | NOVEL ARYLOXY ALKYL AMINES, THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM | LAEVOSAN GMBH & CO KG (AT) | 1994-09-07 | — | — | EP | disclosed |
| US-5334602-A | Antiarrhytmic agent | LAEVOSAN-GESELLSCHAFT GMBH (AT) | 1994-08-02 | — | — | US | disclosed |
| US-5118685-A | Antiarrhythmia agents | BASF AKTIENGESELLSCHAFT (DE) | 1992-06-02 | — | — | US | disclosed |
| EP-0152556-B1 | AMINOPROPANOL DERIVATIVES OF SUBSTITUTED 2-HYDROXY-PROPIOPHENONES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1987-01-21 | — | — | EP | disclosed |
| US-4612320-A | Aminopropanol derivatives of 1-(2-hydroxyphenyl)-3-phenylpropanols and therapeutic agents containing these compounds | BASF AKTIENGESELLSCHAFT (DE) | 1986-09-16 | — | — | US | disclosed |
| EP-0152556-A1 | Aminopropanol derivatives of substituted 2-hydroxy-propiophenones, process for their preparation and therapeutic agents containing them | BASF Aktiengesellschaft (DE) | 1985-08-28 | — | — | EP | disclosed |